Streamlined Schemes for Dosimetry of <sup>177</sup>Lu-Labeled PSMA Targeting Radioligands in Therapy of Prostate Cancer

Streamlined Schemes for Dosimetry of <sup>177</sup>Lu-Labeled PSMA Targeting Radioligands in Therapy of Prostate Cancer

(Background) Aim of this retrospective analysis was to investigate in mCRPC patients treated with [<sup>177</sup>Lu]Lu-PSMA-617 whether the absorbed dose (AD) in organs at risk (OAR, i.e., kidneys and parotid glands) can be calculated using simplified methodologies with sufficient accura...

Full description

Bibliographic Details
Main Authors: Jens Kurth, Martin Heuschkel, Alexander Tonn, Anna Schildt, Oliver W. Hakenberg, Bernd J. Krause, Sarah M. Schwarzenböck
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Cancers
Subjects:
PSMA
therapy
prostate cancer
dosimetry
single time-point
Online Access:https://www.mdpi.com/2072-6694/13/15/3884

Internet

https://www.mdpi.com/2072-6694/13/15/3884

Similar Items